Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-06

Clinical Trial Update: Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of investigational treatments for moderate to severe hidradenitis suppurativa; the study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-06